Temaz and Maxalt-mlt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Maxalt-mlt (rizatriptan benzoate). Common drug interactions include blood pressure increased among females and angiofibroma among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Maxalt-mlt. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Maxalt-mlt?

Maxalt-mlt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 1,534 Maxalt-mlt users. Check the latest studies of Maxalt-mlt.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

17 people who take Temaz and Maxalt-mlt together, and have interactions are studied.

Temaz and Maxalt-mlt drug interactions.

What are the common drug interactions of Temaz and Maxalt-Mlt, by gender? *:

female:

  1. Blood pressure increased
  2. Joint swelling
  3. Loss of consciousness
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Partial seizures (seizures which affect only a part of the brain at onset)
  6. Somnambulism (sleep walking)
  7. Status migrainosus (a migraine headache for 72 hours)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Adhesion
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

male:

  1. Angiofibroma (small, reddish brown or even flesh-coloured, smooth, shiny, 0.1- to 0.3 cm papules present over the sides of the nose and the medial portions of the cheeks)
  2. Anxiety
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Cellulitis (infection under the skin)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Craniocerebral injury (injury to cranium and brain)
  10. Cystocele (a condition that occurs when the tough fibrous wall between a woman's bladder and her vagina is torn by childbirth)

What are the common drug interactions of Temaz and Maxalt-Mlt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Arrhythmia (irregular heartbeat)
  2. Back pain
  3. Bladder pain
  4. Blood pressure increased
  5. Cardiac flutter (abnormal heart rhythm)
  6. Chronic kidney disease
  7. Dehydration (dryness resulting from the removal of water)
  8. Depressed mood
  9. Dizziness
  10. Emotional distress

50-59:

  1. Fall
  2. Pain
  3. Atelectasis (partial or complete collapse of the lung)
  4. Back pain
  5. Bone disorder
  6. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  7. Bradycardia (abnormally slow heart action)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  10. Cellulitis (infection under the skin)

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 41.18%
  2. Sleep Disorder: 4 people, 23.53%
  3. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 23.53%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 17.65%
  5. Panic Disorder: 1 person, 5.88%
  6. Pain: 1 person, 5.88%
  7. Muscle Spasms (muscle contraction): 1 person, 5.88%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
  9. Metastases To Bone (cancer spreads to bone): 1 person, 5.88%
  10. Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Maxalt-mlt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxalt-mlt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxalt-mlt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and rizatriptan benzoate (the active ingredients of Temaz and Maxalt-mlt, respectively), and Temaz and Maxalt-mlt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: